Any professional who started their career in the late 90s, in the financial industry, and in New York City in particular, received a total and utter bath-by-fire by the end of the first decade of the new century. Tumultuous is an understatement and Jacob Gottlieb- Altium saw it all during these days. Largely working in the ridiculously frenetic pharmaceutical and biotech space during the late 90s and early 2000s, there were days when holding onto your hat would have hardly been enough to weather the storms.
Onward and upward he went, from that every-so-trying first years in the business, at Merlin BioMed Group, with the man who cofounded Merlin, and who would prove to be a thread throughout Mr. Gottlieb-Altium’s career, Stuart Weisbrod. Ivy educated at some of the best, including Columbia, Colgate and Princeton, Mr. Weisbrod made the very most of his opportunities in life, earning his PhD in biochemistry, a BA in chemistry and an MBA in finance from Columbia. These 3 degrees represent an amazing string of credentials that would comfortably carry most anyone, through their entire lives, never longing for a job.
Merlin would eventually cease to exist and Mr. Weisbrod would go on to create Iguana Healthcare Partners. Mr. Gottlieb-Altium went on, after Merlin, to found Visium Asset Management eventually growing a $300 million initial capital investment into an $8 billion hedge fund. Visium would see its eventual end and Mr. Gottlieb-Altium would take everything he learned over the years, moving right on to his next venture, creating his eponymous Altium Capital, which also marks the return of his professional focus largely to healthcare concerns.
One of the first investments involved that in the very promising Oramed Pharmaceuticals, which has an oral insulin capsule as one of their flagship products. This will revolutionize the delivery of insulin, sparing millions the task of injections, and will bring a lot more cash into Oramed for more research.
Nowadays, Mr. Gottlieb-Altium and Mr. Weisbrod find themselves back under the same roof, working on developing promising ventures together and celebrating the over 2 decades they spent apart, putting to use all they learned during that time. Someday this will be an even greater success story than it already is.